The significance of multimodality approach in the management of non-lesional drug-resistant focal parietal lobe epilepsies

被引:0
|
作者
Hartnett, Patrick [1 ]
Zomorodi, Naseem [1 ]
Goodkin, Howard P. [1 ]
Zawar, Ifrah [1 ]
机构
[1] Univ Virginia, Sch Med, Dept Neurol, Charlottesville, VA USA
关键词
brain connectivity; drug-resistant epilepsy; interictal epileptiform discharges; parietal lobe epilepsy; seizures; voxel-based morphometry; MAGNETOENCEPHALOGRAPHY; LOCALIZATION;
D O I
10.1002/epi4.13000
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Due to extensive connectivity of the parietal lobe, non-lesional drug-resistant (DRE) parietal lobe epilepsies (PLEs) are difficult to localize and often imitate other epilepsies. Therefore, patients with PLEs have low rates of seizure freedom following epilepsy surgery. Previous studies have highlighted the need to combine EEG and semiology for more accurate localization of PLEs. As sophisticated tools for localization become more available, the use of multiple different neuroimaging and neurophysiologic diagnostic tests may more readily identify PLE. We hereby report a unique case of a complex localization in a non-lesional PLE, which was initially falsely localized to frontal lobe. This case underscores the utility of voxel-based morphometry (VBM) in identifying an epileptogenic lesion on a non-lesional MRI and the significance of multimodality approach including PET, magnetoencephalopathy (MEG), interictal and ictal EEG, semiology and cortical stimulation for accurate localization of PLEs. Understanding epilepsy through multimodality approach in this fashion can help with accurate localization especially in difficulty to localize and deceptive non-lesional PLEs.Plain Language SummaryParietal lobe epilepsies are hard to pinpoint in the brain and can mimic other types of epilepsy, especially when brain MRIs appear normal. As sophisticated tools for locating epilepsies in the brain become more available, using multiple diagnostic tests may help identify parietal lobe epilepsies more easily. We describe a unique case of a parietal lobe epilepsy patient with normal brain MRI whose epilepsy was initially misidentified as being in the frontal lobe. Using various advanced diagnostic tests, we accurately found the epilepsy's true location in the parietal lobe and successfully treated the patient with surgery.
引用
收藏
页码:1604 / 1610
页数:7
相关论文
共 50 条
  • [41] EFFECTS OF COMMONLY USED ANTIEPILEPTIC DRUGS IN THE MTLE MOUSE: A MODEL OF MESIAL TEMPORAL LOBE EPILEPSY TO EXPLORE NEW TREATMENTS FOR DRUG-RESISTANT EPILEPSIES?
    Bressand, K.
    Deransart, C.
    Delotterie, D.
    Bouyssieres, C.
    Dumont, C.
    Roche, Y.
    Langlois, M.
    Roucard, C.
    Depaulis, A.
    EPILEPSIA, 2011, 52 : 256 - 256
  • [42] Multimodal approach leads to seizure-freedom in a case of highly refractory drug-resistant focal epilepsy
    Smith, Kelsey M.
    Alden, Eva C.
    Simpson, Hugh D.
    Brinkmann, Benjamin H.
    Gregg, Nicholas M.
    Miller, Kai J.
    Lundstrom, Brian N.
    EPILEPSY & BEHAVIOR REPORTS, 2022, 20
  • [43] Focal cooling: An alternative treatment for drug-resistant epilepsy in a mesial temporal lobe epilepsy primate model-A preliminary study
    Torres, Napoleon
    de Montalivet, Etienne
    Borntrager, Quentin
    Benahmed, Selimen
    Legrain, Antoine
    Adesso, Eleonora
    Aubert, Nicolas
    Sauter-Starace, Fabien
    Costecalde, Thomas
    Martel, Felix
    Ratel, David
    Gaude, Christophe
    Auboiroux, Vincent
    Piallat, Brigitte
    Aksenova, Tetiana
    Molet, Jenny
    Chabardes, Stephan
    EPILEPSIA, 2024, 65 (07) : 2069 - 2081
  • [44] Spanish consensus on the management of concomitant antiseizure medications when using cenobamate in adults with drug-resistant focal seizures
    Carreno, Mar
    Gil-Nagel, Antonio
    Serratosa, Jose M.
    Toledo, Manuel
    Rodriguez-Uranga, Juan Jesus
    Villanueva, Vicente
    EPILEPSIA OPEN, 2024, 9 (03) : 1051 - 1058
  • [45] Side of Lesions Predicts Surgical Outcomes in Patients With Drug-Resistant Temporal Lobe Epilepsy Secondary to Focal Cortical Dysplasia Type IIIa
    He, Xinghui
    Liu, Dingyang
    Yang, Zhuanyi
    Zhang, Junmei
    Li, Sushan
    Yang, Zhiquan
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [46] Localizing significance of temporal intermittent rhythmic delta activity (TIRDA) in drug-resistant focal epilepsy (vol 114, pg 70, 2003)
    Di Gennaro, G
    Quarato, PP
    Onoratì, P
    Colazza, GB
    Mari, F
    Grammaldo, LG
    Ciccarelli, O
    Meldolesi, NG
    Sebastiano, F
    Manfredi, M
    Esposito, V
    CLINICAL NEUROPHYSIOLOGY, 2003, 114 (05) : 954 - 954
  • [47] Revisiting racial disparities in access to surgical management of drug-resistant temporal lobe epilepsy post implementation of Affordable Care Act
    Sharma, Kanika
    Kalakoti, Piyush
    Henry, Miriam
    Mishra, Vikas
    Riel-Romero, Rosario Maria
    Notarianni, Christina
    Nanda, Anil
    Sun, Hai
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 158 : 82 - 89
  • [48] Hemoperfusion for rapid reduction of bacteria load: a non-pharmaceutical approach for treating drug-resistant bacteremia
    Ward, R.
    McCrea, K.
    White, K.
    Van Zandt, K.
    Bresler, H.
    Judd, A.
    INFECTION, 2017, 45 : S15 - S16
  • [49] Polypharmacy with perampanel for drug-resistant, focal non-convulsive status epilepticus as a manifestation of a stroke-like episode in MELAS
    Finsterer, Josef
    EPILEPSY & BEHAVIOR REPORTS, 2019, 12
  • [50] Evidence on the efficacy of primary radiosurgery or stereotactic radiotherapy for drug-resistant non-neoplastic focal epilepsy in adults: A systematic review
    Eekers, Danielle B. P.
    Pijnappel, Esther N.
    Schijns, Olaf E. M. G.
    Colon, Albert
    Hoeben, Ann
    Zindler, Jaap D.
    Postma, Alida A.
    Hoffmann, Aswin L.
    Lambin, Philippe
    Troost, Esther G. C.
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2018, 55 : 83 - 92